**Core tip:** Fetal akinesia deformation sequence (FADS) is a broad spectrum disorder with absent fetal movements, and its etiology is heterogeneous. Mutations in genes expressed at the neuromuscular junction (NMJ) are increasingly recognized as important causes of FADS. *MUSK* is required for the formation and maintenance of the NMJ. Here we describe a compound heterozygous mutation of the *MUSK* gene that caused FADS in a Chinese fetus.

INTRODUCTION
============

Moessinger proposed that decreased or absent fetal movements, independent of the cause, can lead to a predictable series of secondary anomalies\[[@B1]\]. Clinical symptoms of fetal akinesia deformation sequence (FADS) include joint contractures, subcutaneous edema, fetal hydrops, polyhydramnios, pulmonary hypoplasia, intrauterine growth restriction, micrognathia, cleft palate, hypoplasia of the limb muscles, short umbilical cord, decreased intestinal motility, and shortened bowel, with a phenotype that may be complicated by brain anomalies or restrictive dermopathy. The etiology of FADS is heterogeneous: Both genetic and environmental factors may affect normal develop-mental processes in the fetus and lead to FADS\[[@B2]\]. Mutations in genes expressed at the neuromuscular junction (NMJ) are increasingly recognized as important causes of FADS\[[@B3]\]. *MUSK* is required for the formation and maintenance of the NMJ. To date, two homozygous mutations of *MUSK* have been reported to cause FASD: a c.40dupA mutation\[[@B4]\] and a missense variant \[c.1724T4C; p. (Ile575Thr)\]\[[@B5]\]. Here we describe a compound heterozygous mutation of the *MUSK* gene that caused FADS in a fetus in China and possibly in her sibling.

CASE PRESENTATION
=================

Chief complaints
----------------

Menopause for 6 mo and fetal abnormality for 13 d.

History of present illness
--------------------------

A 34-year-old woman, gravida 2, para 0, abortus 1, was referred to our department because of fetal abnormality. She had regular menstrual cycle before pregnancy, the last menstrual period was February 27, 2017, and the expected date of childbirth was December 3, 2017. She went to prenatal examination regularly, the noninvasive prenatal test result was low risk, the prenatal ultrasound examination showed abnormal ultrasonographic signs and lack of fetal movement. The mother had not felt any fetal movement during pregnancy. The parents decided to terminate the second pregnancy at the gestational age of 24 wk and 3 d of gestation.

History of past illness
-----------------------

A previous pregnancy showed a similarly affected fetus electively aborted at 25 wk of gestation. However, only ultrasound information about the fetus was available with no postnatal findings (case 1 in Table [1](#T1){ref-type="table"}).

###### 

Clinical characteristics of the two study fetuses and fetuses with fetal akinesia deformation sequence syndrome in the literature

  **Article**                     **1**   **2**    **3**                                                                                                                                                                         
  ------------------------------- ------- -------- ------- ------ ----- ------------------------------------ ----- ------------ ------------ ---------- ------------ -------- ------------ ----- ------------ ----- ------------ -----
  GW at birth                     25      24 + 6   27      30     18    18                                   17    41           33 + 4       38 + 1     38 + 4       33 + 1   35           23    32 + 2       22    31           23
  Pregnancy outcome               TOP     TOP      Died    IUFD   TOP   TOP                                  TOP   Died \<2 h   Died \<1 h   Died 5 d   Died \<1 h   IUFD     Died \<1 h   TOP   Died \<1 h   TOP   Died \<2 h   TOP
  Prenatal findings                                                                                                                                                                                                              
  Reduced/absent fetal movement   \+      \+       \+      \+     \+    \+                                   \+    NA           NA           NA         \-           \+       NA           \+    \+           \+    NA           \+
  Joint contractures              \+      \+       \+      \+     \+    \+                                   \+    NA           NA           NA         NA           \+       NA           \+    \+           \+    NA           \+
  Polyhydramnios                  \+      \+       \+      \+     \-    \-                                   \-    NA           \+           \+         \+           \+       \+           \-    \+           \-    \+           \+
  FGR                             \+      \+       \-      \-     \-    \-                                   \-    NA           \+           \-         \-           \-       \-           \-    \+           \-    \-           \-
  Subcutaneous edema              \+      \+       \+      \+     \-    \-                                   \-    NA           NA           NA         NA           \-       NA           \-    \-           \-    NA           \-
  Fetal stomach not visualized    \+      \+       \+      \+     \+    \+                                   \+    NA           NA           NA         NA           NA       NA           NA    NA           NA    NA           NA
  Hydrothorax                     \-      \-       \+      \+     \-    \-                                   \-    NA           NA           NA         NA           NA       NA           NA    NA           NA    NA           NA
  Micrognathia                    \+      \+       \-      \-     \-    \-                                   \-    NA           NA           NA         NA           NA       NA           NA    NA           NA    NA           NA
  Postnatal findings                                                                                                                                                                                                             
  Birth weight                    NA      890      NA      NA     NA    NA                                   NA    2700         1870         3470       3250         1363     1910         551   1610         408   1250         490
  Sex of fetus                    F       F        F       F      M     M                                    F     F            F            M          M            F        M            M     M            F     F            M
  Flex hips                       NA      \+       \+      \+     \+    \+                                   \-    \+           \+           \-         \+           \+       \-           \+    \+           \+    NA           \+
  Hyperextended knees             NA      \+       \+      \+     \+    \+                                   \-    NA           \+           \-         \+           \+       \-           \+    \+           \-    NA           \-
  Flexed elbows                   NA      \+       \+      \+     \+    \+                                   \+    NA           \+           \-         \-           \+       \-           \+    \+           \-    NA           \-
  Clenched fingers                NA      \+       \+      \+     \+    \+                                   \+    NA           \+           \+         \+           \+       \+           \+    \+           \+    NA           \+
  Club/rocker feet                NA      \+       \+      \+     \+    \+[1](#T1FN1){ref-type="table-fn"}   \+    \+           \+           \-         \+           \-       \+           \+    \+           \+    \-           \+
  Low set ear                     NA      \+       \+      \+     \-    \-                                   \+    NA           \+           \-         \-           \+       NA           \+    \+           \+    \+           \-
  Hypertelorism                   NA      \-       NA      NA     NA    NA                                   NA    NA           \+           \+         \-           \+       NA           \+    \+           \+    \-           \+
  Micrognathia                    NA      \+       \+      \-     \+    \+                                   \+    \+           \-           \+         \-           \+       \-           \+    \+           \+    \-           \+
  Cleft palate                    NA      \-       \-      \-     \-    \-                                   \-    \-           \-           \-         \-           \-       \-           \-    \-           \-    \-           \-
  Edema                           NA      \+       \+      \-     \-    \-                                   \+    NA           \-           \-         \+           \-       \-           \+    \+           \-    \-           \+
  Pulmonary hypoplasia            NA      \+       \+      \+     \-    \-                                   \+    \+           \+           \+         \+           \+       \+           \+    \+           \+    NA           \+

The fetus had feet deformity. +: Present; -: Absent. Pedigree 1: The two fetuses in our article. Pedigree 2: The five fetuses reported by Wilbe et al\[[@B4]\]. Pedigree 3: The 11 fetuses diagnosed with a c.1724T \> C mutation reported by Tan-Sindhunata et al\[[@B5]\]. F: Female; M: Male; GW: Gestational week; NA: Not assessed; FGR: Fetal growth restriction; TOP: Termination of pregnancy; IUFD: Intrauterine fetal death.

Personal and family history
---------------------------

The parents were non-consanguineous Chinese, and there was no family history of the parents.

Physical examination upon admission
-----------------------------------

General physical examination was normal. Fatal heart rate was 146 bpm, the height of the uterine fundus was 24 cm, and there was fetal head presentation.

Laboratory examinations
-----------------------

The results of routine blood test were: WBC 1.1 × 10^10^/L, NE 71.0%, RBC 3.56 × 10^12^/L, HGB 115 g/L, and PLT 2.79 × 10^11^/L. K^+^ was 3.99 mmol/L, Na^+^ was 136.3 mmol/L, and Ca^2+^ was 2.32 mmol/L. Routine urine test was normal.

Total genomic DNA was extracted from the aborted fetus' muscular tissue and peripheral blood leukocytes were isolated from the parents according to standard protocols. Targeted enrichment of whole exome DNA was performed using a Nextera Rapid Capture Exome kit (Illumina, San Diego, CA, United States) according to manufacturers' protocols. Whole exome libraries were then sequenced on an Illumina HiSeq platform using a 2 × 100 bp sequencing protocol. Potentially homozygous, compound heterozygous, and *de novo* variants were filtered out. An identified compound heterozygous mutation in the *MUSK* gene was confirmed using standard Sanger sequencing. For amplification of the genomic region that includes the mutations identified in this study, the following two primer pairs were used: (1) GTGGTCGGGATTGACAGCA (forward) and CACAGCTGAAGACCCTGGG (reverse); and (2) CCCAGGGTCTTCAGCTGTG (forward) and CCTCTGTCATGCTGCCCAA (reverse). We found that the fetus carried both a frameshift mutation, c.421delC (p. Pro141Hisfs\*15), and a missense mutation, c.220C \> T (p. R74W) in the *MUSK* gene, involving the same transcript (ENST00000374448.8; Figure [1D](#F1){ref-type="fig"}). After examining the mutation sites of family members, it was determined that fetal mutations were inherited from both parents. The fetus' mother carried the c.220C \> T mutation and the c.421delC mutation was detected in the fetus' father; thus the fetus received two different *MUSK* mutations, one from each parent, resulting in a compound heterozygous mutation.

![An affected family history pedigree. Ultrasound and genetic data revealed a frameshift mutation in muscle, skeletal receptor tyrosine kinase. A: Pedigree of affected family highlights two affected fetuses; B: Photograph of a fetus with fetal akinesia deformation sequence (FADS) from the second pregnancy after an abortion at 25 gestational weeks; C: The second pregnancy displayed polyhydramnios fetal hydrops and micrognathia; D: Sanger sequencing revealed that the mother and father had different heterozygous mutations, and the fetus had a compound heterozygous mutation; E: Mutation sites of c.421delC and c.220C \> T in each species and conserved region; F: Mutation sites of Pro141Hisfs\*15 and p. R74W in each species and conserved region; G: Domain structure of muscle, skeletal receptor tyrosine kinase (*MUSK*) protein and other mutations in *MUSK* previously reported to cause FADS.](WJCC-7-3655-g001){#F1}

Hematoxylin and eosin staining and immunohistochemical staining were performed on muscle biopsies from the affected fetus, and a dead fetus after spontaneous abortion at the same gestational weeks. Immunohistochemical analysis was performed using mouse monoclonal antibodies against slow myosin heavy chain (NCL MHCs; 1:500 dilution), and fast myosin heavy chain (MHCf; 1:500 dilution), both of them were purchased from Abcam (Cambridge, United Kingdom). Significant atrophy was demonstrated in all muscle biopsies. Only a few scattered fibers that were analysed expressed slow myosin. The vast majority of fibers expressed fast myosin. Increased amounts of loose connective tissue were found around and within muscle fascicles. A comparison of MHCf in samples from normal and affected fetuses showed a statistically significant difference between the two, with the affected fetus showing more MHCf (Figure [2](#F2){ref-type="fig"}).

![Histological, immunohistochemical, and Western blot findings. A: Tissues from the affected fetus; A i: Hematoxylin and eosin staining showed a large variation in muscle ﬁber size, with many atrophic ﬁbers and increased amounts of loose connective tissue; A ii: Immunohistochemistry with antibody against slow myosin demonstrated only a few scattered type 1 ﬁbers; A iii: Immunohistochemistry with antibody against fast myosin demonstrated that the majority were muscle ﬁbers; B: The results for a control fetus (dead fetus after a spontaneous abortion after the same number of gestational weeks); C: Western blot indicating that the amount of fast myosin heavy chain was significantly higher in the muscles of the affected fetus compared to the control fetus. The loading control is GAPDH. *P* \< 0.05.](WJCC-7-3655-g002){#F2}

Imaging examinations
--------------------

Prenatal ultrasound signs for the second female fetus included pronated club hands (Figure [1B and C](#F1){ref-type="fig"}) and rocker-bottom feet. In addition, a micromandible, increased nuchal skin thickness (1.05 cm), and fetal hydrops were also noted. Fetal growth was not appropriate for the gestational age and fetal growth restriction was diagnosed. A clinical diagnosis of FADS was made (case 2 in Table [1](#T1){ref-type="table"}).

FINAL DIAGNOSIS
===============

FADS syndrome; G1 P0 G24 wk, delivery of a dead fetus.

TREATMENT
=========

We inducted the labor after routine examinations and consultation of relevant experts.

OUTCOME AND FOLLOW-UP
=====================

The patient was discharged on the third day after abortion and was followed for preimplantation genetic diagnosis (PGD).

DISCUSSION
==========

The unifying feature of FADS is a reduction or lack of fetal movement. The clinical symptoms of the two affected fetuses above and two reviews of several affected fetuses described in the medical literature, including prenatal and postnatal findings, are summarized in Table [1](#T1){ref-type="table"}. Nearly all cases with an affected fetus chose to terminate the pregnancy in the face of reduced/absent fetal movements and joint contractures. Eight neonates died within a few hours or days after birth and none survived during the neonatal period. Six fetuses did not undergo a prenatal assessment and died within a few hours after birth. In this regard, a prenatal examination is always important if FADS is suspected.

Although etiologies are heterogeneous, the prevailing view is that more than half of all FADS cases are of neuromuscular origin. Several causative gene mutations have been identified because of the development of NGS technologies. Gene mutations of proteins at the NMJ are presently recognized as an important cause of FADS, including *CHRNA1* (OMIM 100690)\[[@B6]\], *CHRND* (OMIM 100720)\[[@B6]\], *CHRNG* (OMIM 100730)\[[@B7]\], *DOK7* (OMIM 610285)\[[@B8]\], *RAPSN* (OMIM 601592)\[[@B9]\], and *MUSK* (OMIM601296)\[[@B4]\]. Up to December 31, 2017, *MUSK* mutations have been identified in three families with FADS involving 18 patients, including the present case (Table [1](#T1){ref-type="table"}). The four mutations in the three pedigrees are located in exons (Figure [1G](#F1){ref-type="fig"}). The *MUSK* protein is highly conserved among different species (Figure [1F](#F1){ref-type="fig"}), and hence the full-length protein is important for its function. In this case, the c.421delC frameshift mutation led to the premature termination of *MUSK* protein translation and the generation of a truncated, 154-amino acid protein, which resulted in *MUSK* loss of function. A c.220C \> T missense mutation caused an amino acid substitution at residue 74 from arginine to tryptophan. This site is also highly conserved among different species (Figure [1E](#F1){ref-type="fig"}).

*MUSK* is required for the formation and maintenance of the NMJ. The MUSK protein contains three Ig-like domains: A frizzled-like cysteine-rich domain, a transmembrane helix, and a cytoplasmic tyrosine kinase domain\[[@B10]\] (Figure [1G](#F1){ref-type="fig"}). In this case, c.421delC and c.220C \> T mutations are located in Ig-like 1/2 domains, which are important for the agrin activation of *MUSK*. Histological and immuno-histochemical findings revealed fiber atrophy and a predominance of type II fibers. We proposed that the compound heterozygous mutation caused a loss of the normal function of *MUSK*.

CONCLUSION
==========

In conclusion, we herein have reported the first Chinese case of a compound heterozygous mutation of *MUSK* that caused FADS as an important addition to the *MUSK* gene mutation database. Further investigation of the relationship between the phenotype and genotype of the compound heterozygous mutation will enable a better understanding of this rare disease.
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